🇺🇸 FDA
Patent

US 10100018

Amide derivatives as lysophosphatidic acid receptor antagonists

granted A61KA61K31/195A61K31/277

Quick answer

US patent 10100018 (Amide derivatives as lysophosphatidic acid receptor antagonists) held by Takeda Pharmaceutical Company Limited expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/195, A61K31/277, A61K31/44, A61K31/505